Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Quality summit for the pharma industry
Quality summit for the pharma industry
BusinessLine

The two-day 11th Global Pharmaceutical Quality Summit, organised by the Indian Pharmaceutical Alliance, kicks off today in Mumbai. The industry conclave will be attended by drug regulatory representatives from multiple countries. There will be…

fool.com - Reuben Gregg Brewer - Novartis: This Big Pharma Giant Could Be a Sleep-at-Night Core Holding for Decades
Novartis: This Big Pharma Giant Could Be a Sleep-at-Night Core Holding for Decades
The Motley Fool

Novartis (NVS 0.76%) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and cardiovascular, renal, and metabolic diseases.

globes.co.il - Gali Weinreb - Israeli oncology treatment co Starget Pharma raises $18m
Israeli oncology treatment co Starget Pharma raises $18m
גלובס

Israeli oncological treatment startup Starget Pharma has announced the completion of an $18 million financing round in order to advance its radioactive oncological treatment. The new funding will help the company begin clinical trials in…

theguardian.com - Lisa O’Carroll - UK in talks with US over 'best possible deal' for British firms amid higher tariffs threat
UK in talks with US over 'best possible deal' for British firms amid higher tariffs threat
The Guardian

High-level talks with the US administration over the threat of increased tariffs are under way as the UK government says it wants “the best possible deal” for UK companies. Business leaders said they expected the UK to “double…

thenews.com.pk - Hafsa Naeem Baig - UK seeks 'best possible deal' with US as tariff threat looms
UK seeks 'best possible deal' with US as tariff threat looms
The News International

The UK government is in talks with the U.S. over the ‘best possible deal' for British firms amid the higher tariffs threat. High-level talks with the U.S. administration over the threat of increased tariffs are under way as the business…

seekingalpha.com - ALLKA Research - Merck Stock: Why Investors Should Remain Bullish Despite Patent Risks (NYSE:MRK)
Merck Stock: Why Investors Should Remain Bullish Despite Patent Risks (NYSE:MRK)
Seeking Alpha

Merck started 2026 on a high note. On February 13, its stock reached a 52-week high of $123.3. One of the key reasons Merck is once again becoming a Wall Street favorite is the 6.8% year-over-year increase in sales of pembrolizumab franchise to…

marketbeat.com - Q1 Earnings Forecast for NAMS Issued By HC Wainwright
Q1 Earnings Forecast for NAMS Issued By HC Wainwright
MarketBeat

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for shares of NewAmsterdam Pharma in a research note issued to investors on Thursday, February 19th. HC…

thehindubusinessline.com - Aloe vera, consistent workouts, ashwagandha and magnesium
Aloe vera, consistent workouts, ashwagandha and magnesium
BusinessLine

1. Aloe vera: Up at 6.30 am, I start my morning with two glasses of water with aloe vera. It's a habit I've stayed loyal to, because it creates a calm, predictable start before the day gets demanding. I avoid jumping straight into screens or…

thehindubusinessline.com - Avendus Structured Credit Fund III crosses ₹2200 crore in commitments
Avendus Structured Credit Fund III crosses ₹2200 crore in commitments
BusinessLine

Avendus Group has raised over ₹2,200 crore in commitments for its third structured credit vehicle, triggering a greenshoe option and marking a significant scale-up in its private credit strategy. Avendus Structured Credit Fund III (ASCF…

globalnews.ca - Alan Cross - 5 of the most unattainable records in the universe
5 of the most unattainable records in the universe
Global News

Record collecting has never been hotter. Discogs.com, the de facto online vinyl bible, has a Top 50 list of the most expensive records sold to mere mortals, which range from the obscure (a 2008 12-inch single by Scaramanga Silk that sold on the…

koreaherald.com - Kan Hyeong-woo - China scales biotech, Korea carves a niche
China scales biotech, Korea carves a niche
The Korea Herald

Facing China's scale advantage, Korea pushes for looser listing rules, cash-based R&D credits, venture ecosystem overhaul China's biopharmaceutical rise is no longer incremental — it is structural, accelerated and globally consequential. So…

marketbeat.com - Johnson & Johnson $JNJ Shares Acquired by Vestmark Advisory Solutions Inc.
Johnson & Johnson $JNJ Shares Acquired by Vestmark Advisory Solutions Inc.
MarketBeat

Vestmark Advisory Solutions Inc. lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 47.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm…

marketbeat.com - Johnson & Johnson $JNJ Shares Purchased by Westerkirk Capital Inc.
Johnson & Johnson $JNJ Shares Purchased by Westerkirk Capital Inc.
MarketBeat

Westerkirk Capital Inc. grew its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 28.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,059 shares…

marketbeat.com - Johnson & Johnson $JNJ Shares Acquired by Lansforsakringar Fondforvaltning AB publ
Johnson & Johnson $JNJ Shares Acquired by Lansforsakringar Fondforvaltning AB publ
MarketBeat

Lansforsakringar Fondforvaltning AB publ lifted its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 2.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned…

marketbeat.com - FY2027 Earnings Forecast for VRTX Issued By Erste Group Bank
FY2027 Earnings Forecast for VRTX Issued By Erste Group Bank
MarketBeat

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Investment analysts at Erste Group Bank issued their FY2027 earnings per share (EPS) estimates for shares of Vertex…

Receive a Daily briefing on Pharma Industry News

Get Started